Join to View Full Profile
55 Fruit Street Yawkey 7604Mass General Physician OrganizationCharlestown, MA 02129
Phone+1 617-726-2782
Fax+1 617-726-2894
Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
Harvard Medical SchoolClass of 2002
Certifications & Licensure
FL State Medical License 2022 - Present
MA State Medical License 2004 - 2027
VT State Medical License 2023 - 2026
NH State Medical License 2024 - 2024
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer Start of enrollment: 2010 Apr 14
- A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer Start of enrollment: 2011 Apr 01
- A Study of BBI503 in Adult Patients With Advanced Solid Tumors Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial.Panagiotis A Konstantinopoulos, Ningxuan Zhou, Richard T Penson, Tien V Le, Susana Campos
Nature Communications. 2025-12-03 - The impact of romiplostim use for chemotherapy induced thrombocytopenia on immediate and long-term outcomes in gynecologic malignancies.Surabhi Tewari, Ellery Koelker-Wolfe, Andrea Pelletier, Jessica St Laurent, Susana Campos
Gynecologic Oncology. 2025-12-01 - 3 citationsADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uter...Joyce F Liu, Nicoletta Colombo, Amit M Oza, Jean-Sebastien Frenel, Bradley R Corr
Journal of Clinical Oncology. 2025-09-10
Press Mentions
Nivolumab/bevacizumab Combo Promising in Relapsed Ovarian CancerOctober 19th, 2019
OncLive® Presents Latest State of the Science Summit™ on Ovarian Cancer and STSNovember 29th, 2018
Update Sustains Olaparib/Cediranib PFS Benefit in Ovarian CancerJune 9th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
